Pyxis Oncology Inc
Pyxis Oncology Inc (PYXS) Straddle
PYXS straddle scan found 9 qualifying long straddle setups on the previous trading day. Probability of profit reaches up to 67.8%.
Read more
Trading a PYXS straddle lets you take a pure volatility position on Pyxis Oncology Inc without committing to a direction. Pyxis Oncology Inc's straddle involves buying (or selling) a call and a put at the same strike and expiration, profiting when the stock moves more (or less) than the combined premium implies. Use our scanner to evaluate PYXS straddle pricing in real time and find the moments when expected moves are mispriced.
A long straddle on PYXS profits from large moves in either direction and is a classic play into binary events like earnings, product announcements, or macro releases. A short straddle profits when Pyxis Oncology Inc stays range-bound and implied volatility contracts. The breakeven points are simple: strike plus total premium on the upside, strike minus total premium on the downside. Comparing the PYXS straddle price to historical realized moves helps you judge whether the market is overpaying or underpaying for volatility.
Pyxis Oncology, Inc., a preclinical stage biopharmaceutical company, engages in the development of therapies to treat cancers. Its immune-oncology product candidates include PYX-106, an investigational fully human immunoglobulin G1 isotype siglec-15 targeting antibody for the treatment of thyroid cancer, head and neck squamous cell carcinoma, non-small cell lung cancer (NSCLC), and other solid tumors; and PYX-102, an investigational immune-therapeutic for treatment of solid tumors. The company's antibody drug conjugate (ADC) product candidates comprise of PYX-201, an investigational novel ADC to treat NSCLC, breast cancer, and other solid tumors; PYX-202, an investigational novel ADC for treatment of SCLC, soft tissue sarcoma, and other solid tumors; and PYX-203, an investigational ADC for the treatment of acute myeloid leukemia and myeloid dysplastic syndrome.
The company was incorporated in 2018 and is headquartered in Cambridge, Massachusetts.
Earnings, product cycles, macro prints — any time volatility itself is the trade, the PYXS straddle is the cleanest expression of that view. Our scanner prices every PYXS straddle against historical realized moves, flags expirations where the market is overpaying or underpaying for vol, and ranks setups by breakeven width and IV rank. Whether you're long a PYXS straddle into a catalyst or short a PYXS straddle to harvest decay, the options straddle setups that matter are all in one place.
| Apr 16, 2027 | 7.50 | $5.30 | 210 | 35% | 67.8% | $12.80 | $2.20 | 0 |
| Apr 16, 2027 | 5.00 | $3.33 | 210 | 35% | 64.0% | $8.33 | $1.68 | 6 |
| Jan 15, 2027 | 5.00 | $2.80 | 119 | 35% | 61.7% | $7.80 | $2.20 | 3 |
| Oct 16, 2026 | 7.50 | $4.13 | 28 | 35% | 60.6% | $11.63 | $3.38 | 1 |
| Oct 16, 2026 | 5.00 | $1.88 | 28 | 35% | 58.2% | $6.88 | $3.13 | 127 |
| Oct 16, 2026 | 2.50 | $1.05 | 28 | 35% | 42.5% | $3.55 | $1.45 | 192 |
| Apr 16, 2027 | 2.50 | $2.20 | 210 | 35% | 30.2% | $4.70 | $0.30 | 48 |
| Jan 15, 2027 | 2.50 | $2.05 | 119 | 35% | 27.6% | $4.55 | $0.45 | 160 |
| Nov 20, 2026 | 2.50 | $1.93 | 63 | 35% | 24.7% | $4.43 | $0.58 | 0 |
As of September 18, 2026
Find the right straddle before volatility moves
Track PYXS straddle pricing across expirations, filter by IV rank and breakeven points, and build a setup that fits your view before the move happens.
Start your 14-day free trial→